Position in VCYT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$834,494
+$541,138 QoQ
Shares Held
14,209
+30.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#182
of 367 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $22,258,629 across 6 Diagnostics & Research names. VCYT ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
35,160 | $17,627,817 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
2,481 | $1,313,912 | |
| 3 | DHR |
Danaher Corp /De/
|
6,172 | $1,175,642 | |
| 4 | MYGN |
Myriad Genetics Inc
|
178,546 | $1,019,497 | |
| 5 | VCYT |
Veracyte, Inc.
This page
|
14,209 | $834,494 | |
| 6 | QGEN |
Qiagen N.V.
|
7,347 | $287,267 |
All Filings in VCYT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $834,494 | 14,209 | Shares | Sole | 2026-08-13 | |
| 2025-06-30 | $293,356 | 10,853 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $547,131 | 18,453 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $952,617 | 24,056 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $903,898 | 26,554 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $652,375 | 30,105 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $522,998 | 23,601 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $389,899 | 14,173 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $318,671 | 14,271 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $363,635 | 14,277 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $251,432 | 11,275 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $241,167 | 10,163 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||